Microbot Medical
MBOT
MBOT
36 hedge funds and large institutions have $2.57M invested in Microbot Medical in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4.68% more ownership
Funds ownership: 8.57% → 13.26% (+4.7%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Holders
36
Holding in Top 10
–
Calls
$109K
Puts
$67K
Top Buyers
| 1 | +$492K | |
| 2 | +$325K | |
| 3 | +$95K | |
| 4 |
Morgan Stanley
New York
|
+$42.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$33.2K |
Top Sellers
| 1 | -$71.4K | |
| 2 | -$54.9K | |
| 3 | -$28.9K | |
| 4 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$16K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$15K |